Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysis

BACKGROUND: A series of clinical trials support the effectiveness of monoclonal antibodies for generalized myasthenia gravis (MG) compared to the placebo, but the priority among drugs remains unclear. Therefore, we conduct a frequentist network meta-analysis (NMA) to compare the relative effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huiru, Qiu, Youjia, Yin, Ziqian, Wang, Zilan, Tang, Yanbing, Ni, Hanyu, Lu, Jiaye, Chen, Zhouqing, Kong, Yan, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663412/
https://www.ncbi.nlm.nih.gov/pubmed/38022544
http://dx.doi.org/10.3389/fimmu.2023.1280226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663412/
https://www.ncbi.nlm.nih.gov/pubmed/38022544
http://dx.doi.org/10.3389/fimmu.2023.1280226

Ejemplares similares